Page last updated: 2024-12-08

neomyosuppressin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

neomyosuppressin: myoinhibiting neuropeptide from the grey fleshfly, Neobellieria bullata & Drosophila [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID197486
MeSH IDM0208992

Synonyms (6)

Synonym
neomyosuppressin
dromyosuppressin
neb-ms
leucomyosuppressin, 1-l-threonine-
threonyl-aspartyl-valyl-aspartyl-histidyl-valyl-phenylalanyl-leucyl-arginyl-phenylalanine amide
143458-86-0
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (35.71)18.2507
2000's4 (28.57)29.6817
2010's4 (28.57)24.3611
2020's1 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]